206 related articles for article (PubMed ID: 20965162)
21. Postnatal programming of glucocorticoid metabolism in rats modulates high-fat diet-induced regulation of visceral adipose tissue glucocorticoid exposure and sensitivity and adiponectin and proinflammatory adipokines gene expression in adulthood.
Boullu-Ciocca S; Achard V; Tassistro V; Dutour A; Grino M
Diabetes; 2008 Mar; 57(3):669-77. PubMed ID: 18057089
[TBL] [Abstract][Full Text] [Related]
22. Pioglitazone prevents hyperglycemia induced decrease of AdipoR1 and AdipoR2 in coronary arteries and coronary VSMCs.
Shen X; Li H; Li W; Wu X; Ding X
Mol Cell Endocrinol; 2012 Nov; 363(1-2):27-35. PubMed ID: 22820128
[TBL] [Abstract][Full Text] [Related]
23. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients.
Crespo J; Cayón A; Fernández-Gil P; Hernández-Guerra M; Mayorga M; Domínguez-Díez A; Fernández-Escalante JC; Pons-Romero F
Hepatology; 2001 Dec; 34(6):1158-63. PubMed ID: 11732005
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.
Asano T; Watanabe K; Kubota N; Gunji T; Omata M; Kadowaki T; Ohnishi S
J Gastroenterol Hepatol; 2009 Oct; 24(10):1669-76. PubMed ID: 19788607
[TBL] [Abstract][Full Text] [Related]
25. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?
Hui JM; Hodge A; Farrell GC; Kench JG; Kriketos A; George J
Hepatology; 2004 Jul; 40(1):46-54. PubMed ID: 15239085
[TBL] [Abstract][Full Text] [Related]
26. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
27. Roux-en-Y gastric bypass alters tumor necrosis factor-α but not adiponectin signaling in immediate postoperative period in obese rats.
Rideout DA; Peng Y; Rakita SS; Desai K; Gower WR; You M; Murr MM
Surg Obes Relat Dis; 2010; 6(6):676-80. PubMed ID: 20702148
[TBL] [Abstract][Full Text] [Related]
28. A novel non-alcoholic steatohepatitis animal model featured with insulin resistance, hepatic inflammation and fibrosis.
Zhao J; Zhou G; Li M; Li W; Lü J; Xiong L; Liang L; Zhao Y; Xu D; Yu J
Scand J Gastroenterol; 2010 Nov; 45(11):1360-71. PubMed ID: 20560816
[TBL] [Abstract][Full Text] [Related]
29. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
[TBL] [Abstract][Full Text] [Related]
30. Anti-metabolic syndrome effects of adenosine ingestion in stroke-prone spontaneously hypertensive rats fed a high-fat diet.
Ardiansyah ; Shirakawa H; Sugita Y; Koseki T; Komai M
Br J Nutr; 2010 Jul; 104(1):48-55. PubMed ID: 20175942
[TBL] [Abstract][Full Text] [Related]
31. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
[TBL] [Abstract][Full Text] [Related]
32. [The role of adiponectin and adiponectin receptor 2 in the pathology of fatty liver].
Li HS; Feng Q; Hu YY; Chen SD; Peng JH; Li XM; Xu LL
Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):826-30. PubMed ID: 19958641
[TBL] [Abstract][Full Text] [Related]
33. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
[TBL] [Abstract][Full Text] [Related]
34. Additive action of 11beta-HSD1 inhibition and PPAR-gamma agonism on hepatic steatosis and triglyceridemia in diet-induced obese rats.
Berthiaume M; Laplante M; Festuccia WT; Berger JP; Thieringer R; Deshaies Y
Int J Obes (Lond); 2009 May; 33(5):601-4. PubMed ID: 19223847
[TBL] [Abstract][Full Text] [Related]
35. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease.
Musso G; Gambino R; Durazzo M; Biroli G; Carello M; Fagà E; Pacini G; De Michieli F; Rabbione L; Premoli A; Cassader M; Pagano G
Hepatology; 2005 Nov; 42(5):1175-83. PubMed ID: 16231364
[TBL] [Abstract][Full Text] [Related]
36. Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats.
Pérez-de-Heredia F; Sánchez J; Priego T; Nicolás F; Portillo Mdel P; Palou A; Zamora S; Garaulet M
Steroids; 2008 Oct; 73(11):1128-36. PubMed ID: 18534650
[TBL] [Abstract][Full Text] [Related]
37. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.
Sutinen J; Kannisto K; Korsheninnikova E; Fisher RM; Ehrenborg E; Nyman T; Virkamäki A; Funahashi T; Matsuzawa Y; Vidal H; Hamsten A; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E941-9. PubMed ID: 14749206
[TBL] [Abstract][Full Text] [Related]
38. Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment.
Liu Y; Chewchuk S; Lavigne C; Brûlé S; Pilon G; Houde V; Xu A; Marette A; Sweeney G
Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E657-64. PubMed ID: 19531641
[TBL] [Abstract][Full Text] [Related]
39. Undernutrition during suckling in rats elevates plasma adiponectin and its receptor in skeletal muscle regardless of diet composition: a protective effect?
Prior LJ; Velkoska E; Watts R; Cameron-Smith D; Morris MJ
Int J Obes (Lond); 2008 Oct; 32(10):1585-94. PubMed ID: 18725894
[TBL] [Abstract][Full Text] [Related]
40. Adiponectin receptors: expression in Zucker diabetic rats and effects of fenofibrate and metformin.
Metais C; Forcheron F; Abdallah P; Basset A; Del Carmine P; Bricca G; Beylot M
Metabolism; 2008 Jul; 57(7):946-53. PubMed ID: 18555836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
